ijas

International Journal Of Advances In Surgery


ISSN (O) : 2663 - 046X

A CrossRef Indexed Journal

DOI : 10.34300/26630451

ISSN (P) : 2663 - 0451

IC VALUE : 92.22 (2019)


Research Paper

The Effectiveness of Intravitreal Aflibercept in the Treatment of Neovascular Age-Related Macular Degeneration

Dr. Burak Simsek

Abstract :

PURPOSE:To evaluate the effectiveness of intravitreal aflibercept in neovascular age-related macular degeneration (AMD) patients followed in our clinic. METHOD:The examination file and optical coherence tomography (OCT) datas were investigated retrospectively.Patients divided into two groups according to previous therapies: patients received treatment before aflibercept (Group1) and started treatment with aflibercept (Group2).In Group2,patients were treated with pro-re-nata (PRN) regimen after 3 loading doses monthly.In Group1 patients were treated directly with PRN regimen after switching to aflibercept. RESULTS:154 eyes of 116 patients were enrolled. Average age of the patients were 75,2.The average follow-up duration was 39,01 months.The differences between the groups were statistically insignificant according to the sex,laterality of the eye and the post-aflibercept therapies (p>0,05).The number of aflibercept injections in Group2 was significantly higher than Group1 (p<0,05).VA changes both in the groups and between the groups were not significant in post-aflibercept and last visits,in comparison with the VA values before aflibercept injection (p>0,05).In Group1,central and average macular thickness in post-aflibercept and last visits were significantly thinner than pre-aflibercept visit (p<0,05).In Group2, the difference of central macular thickness values between pre and post-aflibercept visits was significant (p<0,05),however the difference between pre-aflibercept and last visits was not (p>0,05). In Group2, the average macular thickness values in both post-aflibercept and last visits were significantly thinner than the pre-aflibercept visit (p<0,05).Changes in macular thickness values between two groups were statistically insignificant (p>0,05). CONCLUSION:In treatment of neovascular AMD,intravitreal aflibercept is an effective method to avoid VA loss and to heal macular morphology.


Keywords :

Aflibercept   neovascular   age related macular degeneration   intravitreal   AMD.  


Cite This Article:

THE EFFECTIVENESS OF INTRAVITREAL AFLIBERCEPT IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION, Dr. Burak Simsek, INTERNATIONAL JOURNAL OF ADVANCED MEDICINE : Volume-1 | Issue-5 | September-2017

References :


[ Download PDF ] [ Number of Downloads : 379 ]

This work is licensed under a Creative Commons Attribution 4.0 International License.
Disclaimer: Articles on International Journal of Advances In Surgery have been previewed and authenticated by the Authors before sending the publication for print.
The Journal, Editor and the Board of Members are not entitled or liable to either justify or responsible for inaccurate and misleading data if any.
It is the sole responsibility of the Author concerned. If any queries or infringement occurs

Copyrights © 2020: International Journal of Advances In Surgery (IJAS)